Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
Cell Cycle (Georgetown, Tex.)|September 22, 2010
The DNA-dependent protein kinase (DNA-PK): More than just a case of making ends meet?Richard Hill, Patrick W K LeeMethods in Molecular Biology (Clifton, N.J.)|September 28, 2011
Exploring host factors that impact reovirus replication, dissemination, and reovirus-induced cell death in cancer versus normal cells in cultureMaya Shmulevitz, Patrick W K LeeFrontiers in Oncology|May 1, 2014
Oncolytic virus-mediated reversal of impaired tumor antigen presentationShashi A Gujar, Patrick W K LeeDrug Discovery Today|June 23, 2005
Not all viruses are bad guys: the case for reovirus in cancer therapyKara L Norman, Patrick W K LeeOncogene|November 22, 2005
Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancerMaya Shmulevitz, Paola Marcato, Patrick W K LeeAutophagy|June 28, 2012
Viral subversion of autophagy impairs oncogene-induced senescenceAndrew M Leidal, Patrick W K Lee, Craig McCormickMolecular Cancer Therapeutics|October 28, 2010
Reovirus virotherapy overrides tumor antigen presentation evasion and promotes protective antitumor immunityShashi A Gujar, Paola Marcato, Da Pan, et al.Cell Cycle (Georgetown, Tex.)|August 23, 2008
p53 Binding to the p21 promoter is dependent on the nature of DNA damageRichard Hill, Ewelina Bodzak, Michael D Blough, et al.Cell Cycle (Georgetown, Tex.)|January 23, 2009
p21Cip1/WAF1 mediates cyclin B1 degradation in response to DNA damageLaura D Gillis, Andrew M Leidal, Richard Hill, et al.Cell Cycle (Georgetown, Tex.)|May 10, 2011
Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoformPaola Marcato, Cheryl A Dean, Carman A Giacomantonio, et al.Pageof 6